Heart Failure meetings & conferences

Controversies and Advances in the Treatment of Cardiovascular Disease: The Twelfth in the Series

September 21–22, 2012 Beverly Hills, California

We are proud to be celebrating the twelfth annual Controversies and Advances in the Treatment of Cardiovascular Disease symposium this year! The two-day scientific program will offer realistic views on many controversial topics, inlcuding coronary artery and left main disease, atrial fibrillation, valvular heart disease, mitral valve disease, chronic heart failure in the elderly and obese, adult congenital heart disease, and atrial septal defect.

The scientific program will consist of sessions focused on treatment options for specific cardiovascular disease states. Each session will include a combination of case presentations, cross-fires, discussion panels, and question and answer periods. A faculty of internationally known leaders in the field has been invited to share their knowledge and experiences with complex and controversial cases.

This conference is designed for cardiologists, cardiovascular and thoracic surgeons, interventional cardiologists, perfusionists, nurses, technologists, and those involved in the diagnosis, treatment, and care of individuals with controversial and complex cases of cardiac disease.
 

Asian Pacific Society of Cardiology 2013 Congress (APSC 2013)

February 21-24, 2013 Pattaya, Thailand

The Asian Pacific Society of Cardiology 2013 Congress (APSC 2013) or the 19th Asia Pacific Congress of Cardiology is a major regional event that aims to facilitate a discussion about the best practices and latest advances in cardiology diseases across the Asia Pacific region. With its strong global presence, APSC 2013 will provide unique networking opportunitites for local and regional professionals working in the fields of cardiovascular diseases and related topics. APSC 2013 will feature an exciting scientific program comprised of both international and local perspectives on the most pertinent issues of the day. The congress will be held in Pattaya, Thailand, once a quiet fishing town that has developed into a major seaside destination. Located a mere two hours from the capital city of Bangkok, Pattaya will enchant you with its many attractions and activities, including the Sri Racha Tiger Zoo, Sanctuary of Truth and much more.

The biennial APSC has gained the distinction of having metamorphosed into the largest continental component of the World Heart Federation - facilitating discussion of current issues and technological challenges faced by Cardiology specialists.

Themed "Towards Excellence and Wisdom in Cardiovascular Care: Asia Pacific's Commitment to the Art & Science of Medicine" the APSC 2013 aims to bring together the best minds in the field of Cardiology to share and exchange their views, knowledge, and expertise.

The Scientific Program of APSC 2013 will cover a wide-range of issues including considerable advances in recent years, especially in the areas of molecular medicine, genomic and cell therapy, development of new diagnostic and screening tools, including biochemical markers and cardiac imaging modalities, new drugs and devices using state-of-the-art bioengineering techniques, and a phenomenal amount of data on the results of uncountable numbers clinical trials in cardiovascular diseases management, in which many of them created a significant controversy. We guarantee that you will find this conference riveting and informative.

Contact Us

If you have any questions regarding The Asian Pacific Society of Cardiology 2013 Congress (APSC 2013), please do not hesitate to contact us;

Email: apscoffice2013@apsc2013.org

Tel: + 66 (0) 2 748-7881
Fax: + 66 (0) 2 748-7880

Kenes Asia (Thailand Office)
PICO Building, 10 Soi Lasalle 56
Sukhumwit, Bangna, Bangkok 10260
THAILAND

International Academy of Cardiology, 17th World Congress on Heart Disease Annual Scientific Sessions 2012

July 27-30, 2012 Toronto, Ontario, Canada

The Congress will provide the opportunity for a comprehensive overview of the latest research developments in cardiovascular medicine, primarily in the areas of molecular biology, coronary artery disease, heart failure, cardiac arrhythmias and cardiac surgery.

Many distinguished cardiologists and scientists have agreed to join the faculty participating in this Congress. Papers will be presented in the form of plenary sessions, symposia and posters, and will include superb scientific material originating from numerous laboratories around the globe, assuring that the meeting will be a major scientific event.

Program areas will range from clinical pathophysiology to evaluation and stratification techniques and molecular and cellular biology, including neurohumoral, immunological and genetic studies. We will discuss new and innovative diagnostic methods, prevention and treatment of heart disease, and prognostic algorithms. Integrated into the program will be an update on the latest major clinical trials.

For further information:

International Academy of Cardiology
17th World Congress on Heart Disease
Annual Scientific Sessions 2012
PO Box 17659, Beverly Hills, CA 90209, USA
Tel: +1 310 657 8777; Fax: +1 310 659 4781
e-Mail: Klimedco@ucla.edu

3rd International Congress on Abdominal Obesity

July 9-12, 2012 Québec City, Québec, Canada

The 3rd International Congress on Abdominal Obesity (ICAO 2012) is a highly anticipated event that will build on the success of last year’s Congress, held in Buenos Aires, Argentina. The Congress’s primary objective is to bring together medical professionals from all specialties to exchange ideas and information and raise awareness of abdominal obesity as a new modifiable risk factor which, along with traditional risk factors, plays a central role in this new concept of global cardiometabolic risk.

This relatively new Congress’s innovative multidisciplinary approach has facilitated the development of a new medical paradigm, whereby complications as hypertension, dyslipidemia, type 2 diabetes, and cardiovascular disease are no longer evaluated and treated in isolation.

We look forward to seeing you in Québec City, Québec, Canada, for what promises to be an exciting and cutting edge gathering of medical professionals of varied interests and backgrounds.

Abstract Topics

Abdominal Obesity/Body Fat Distribution
Acute Coronary Syndromes
Adipokines
Adipose Tissue
Cardiometabolic Risk
Cardiovascular Disease
Childhood Obesity
Clinical Cardiology
Clinical Trials
Diabetes
Ectopic Fat
Epidemiology
Ethnicity
Gender Differences
Genetics
Hypertension
Inflammation
Insulin Resistance
Interventional Cardiology
Lipids/Lipoproteins
Metabolic Syndrome
Nutrition
Obesity
Pathophysiology/Basic Science/Animal Studies
Pathophysiology/Clinical Science/Human Studies
Physical Activity/Exercise
Prevention
Smoking
Steroid Hormones
Thrombosis

Contact Us

Kenes International
1-3 Rue de Chantepoulet
PO Box 1726
CH-1211 Geneva 1, Switzerland
Tel: +41 22 908 0488
Fax: +41 22 906 9140
Email: icao@kenes.com

CSI 2012 - Catheter Interventions in Congenital & Structural Heart Disease

June 28 to 30, 2012 Frankfurt, Germany

CSI will give you a comprehensive overview of major topics in catheter therapy of congenital and structural heart disease both in adults and children. The congress is designed specifically for adult and pediatric interventionalists as well as cardiovascular surgeons and those colleagues of other specialities who want to get an update on these techniques.

Our program will include lectures from the leading experts in the field, live case demonstrations and industry exhibition. We have invited experts from all over the world to give you the opportunity to appreciate different practical approaches and diverse opinions.

As we want to encourage interactive dialogues you will be able to engage in vivid discussions with the panel at any time throughout the live cases and after each lecture. We will have a variety of concurrent focussed Lunch and Evening Sessions which allow even more direct interaction with the experts in the field.

We hope that the CSI 2012 will offer you an exciting experience in learning the latest techniques, seeing the newest devices and meeting the most experienced interventionalists.

Who should attend

The congress is designed specifically for adult and pediatric interventionalists as well as cardiovascular surgeons and those colleagues of other specialities who are interested in these topics.

Learn more about

New ASD/PFO Closure Devices
New Aortic Valves
Catheter Interventions in Infants
Retrieval Techniques
Breaktroughs in Cardiac Surgery

CSI 2012 — Topics

Congenital Heart Interventions

How to Close Atrial and Ventricular Septal Defects
How to use Balloons and Stents in Coarctation and Pulmonary Artery Stenoses
How to Close Large Patent Ductus and Pulmonary AV Fistulae

Structural Heart Interventions

How and When to Close Patent Foramen Ovale to Prevent Paradoxical Embolism
How to Close Post Myocardial Infarction Ventricular Septal Defects
How to Close the Left Atrial Appendage to Prevent Embolic Stroke in Atrial Fibrillation
How to Treat Heart Failure by Catheter Techniques

Valvular Heart Interventions

How to Close Paravalvular Leaks
How to Repair Heart Valves by Catheter Techniques
How to Implant Heart Valves Percutaneously
How to Perform a Valvuloplasty

Pan American Heart Failure Congress (PAHF 2012)

October 18-21, 2012 Panama City, Panama

Cardiovascular disorders are the main cause of morbidity and mortality in many countries around the world including Latin American countries. The Pan American Congress on Heart failure will provide an in-depth focus on the best approaches for preventing and treating heart failure (HF) of various etiologies. Topics range from early recognition and intervention in high risk patients to the expanding use of drugs and devices to monitor and treat heart failure and detect evidence of worsening. The curriculum includes updates on treatment of systemic and pulmonary hypertension management of patients with HF due to coronary disease, acute decompensate HF, systolic and diastolic HF, cardiomyopathies and valvular heart disease. Atrial fibrillation, use of biomarkers and devices to aid in diagnosis, expanding indications for implantable defibrillators and cardiac resynchronization therapy, as well as treatment of sleep apnea and stem cell therapy.

Secretariat: Paragon Conventions
Tel: +41 22 5330 948, Fax: +41 22 5802 953
Email: secretariat@pahfcongress.com